Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

UFS Dean presents lecture at the University of Cambridge
2009-10-09

 
Here at the main entrance (the "Chimney") of the Jesus College, after the certificate ceremony, are from far left: Prof. Barry Rider, Faculty of Law, University of Cambridge and Hosei Project leader, a group of students (Masters degree in Law) of the Faculty of Law from the Hosei University who received competency certificates after successfully completing the Hosei Summer School Project at the Jesus College, Prof. Henning, and Ms Li-hong Xing, Senior Research Fellow in the Centre for International Documentation on Organised and Economic Crime, Cambridge and Hosei Project Administrator.
Photo: Supplied

Prof. Johan Henning, Dean of the Faculty of Law at the University of the Free State (UFS) and Head of the Centre for Business Law at this faculty, delivered three papers during this year’s Cambridge International Symposium on Economic Crime that took place at Jesus College at the University of Cambridge in Cambridge. The theme of this 27th symposium was: “The enemy within – internal threats to the stability and integrity of financial institutions”.

Prof. Henning’s presentations were about: “Conflicts of interest and duty – a persistent threat”, “Data security and identity fraud” and “The responsibility of management for the prevention and control of financial crime-related risks”.

Over and above the three papers he delivered, Prof. Henning was also part of the secretariat of the symposium and he acted as chairperson at some of the workshops.

The UFS’s Faculty of Law was once again very much involved in the organisation and participation of the symposium. Since 1992, the Centre for Business Law of the Faculty of Law has been one of a few organising institutions of this popular and well-known symposium.

Prior to the symposium, Prof. Henning also acted as guest professor at the week-long Hosei Summer School Project that is presented by the Faculty of Law of the Hosei University (Tokyo Japan) in cooperation with the University of Cambridge. He presented two extended workshops for LLM students on International Business Law and Comparative Company Law.

Prof. Henning is also a Professorial Fellow at the Jesus College and a principal lecturer in International Mercantile Law at the Hosei University Summer School.




 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept